Skip to main content
. Author manuscript; available in PMC: 2022 May 4.
Published in final edited form as: Biochim Biophys Acta Proteins Proteom. 2018 Mar 18;1866(7):831–839. doi: 10.1016/j.bbapap.2018.03.006

Table 1.

Socio-demographic and clinical data related to PTSD for the subjects enrolled in the study; where the PTSD Checklist (PCL) and Clinician Administered PTSD Scale for D-serine is a potential biomarker of clinical response to the treatment of post-traumatic stress disorder using (R,S)-ketamine infusion and TIMBER psychotherapy: A pilot study*.

Subject Age (years) Gender Years of education Type of trauma Duration of PTSD (years) PCL CAPS
1 30 F 14 Sexual abuse 18 76 95
2 44 F 10 Physical & emotional abuse 6 77 86
3 57 F 9 Sexual abuse 34 80 84
4 38 F 12 Physical & sexual abuse 18 82 92
5 51 M 16 Stabbing 10 76 96
6 56 F 14 Physical & sexual abuse 29 77 81
7 44 M 18 Sexual abuse 28 60 72
8 37 F 11 Physical & sexual abuse 2 81 97
9 24 F 14 Sexual abuse 9 81 95
10 49 M 12 Motor vehicle accident 38 62 86
11 32 M 17 Physical & sexual abuse 5 60 74
12 40 M 11 Physical & emotional abuse 8 66 82
13 32 M 15 Combat related injury 5 75 96
14 28 M 10 Physical & sexual abuse 11 75 98
15 37 F 11 Physical & sexual abuse 12 75 93
16 32 F 15 Physical & sexual abuse 12 70 92
17 40 M 14 Motor vehicle accident 14 70 83
18 41 F 16 Physical & sexual abuse 20 67 89
19 42 F 13 Physical & emotional abuse 7 76 94
20 60 F 15 Physical & sexual abuse 18 67 92